Get the Stockscreener App
0.7207
2.05%
0.0145
After Hours:
.71
-0.0107
-1.48%
Nautilus Biotechnology Inc stock is traded at $0.7207, with a volume of 280.87K.
It is up +2.05% in the last 24 hours and up +1.09% over the past month.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
See More
Previous Close:
$0.7062
Open:
$0.7475
24h Volume:
280.87K
Relative Volume:
0.87
Market Cap:
$91.03M
Revenue:
-
Net Income/Loss:
$-70.78M
P/E Ratio:
-1.287
EPS:
-0.56
Net Cash Flow:
$-61.27M
1W Performance:
+9.03%
1M Performance:
+1.09%
6M Performance:
-36.78%
1Y Performance:
-73.60%
1-Day Range:
$0.7101
$0.75
1-Week Range:
$0.6521
$0.75
52-Week Range:
$0.62
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Name
Nautilus Biotechnology Inc
Sector
Industry
Phone
206-333-2001
Address
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.7207 | 89.30M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-06-22 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-02-21 | Initiated | Cowen | Outperform |
| Aug-04-21 | Initiated | Goldman | Neutral |
| Jul-13-21 | Initiated | Jefferies | Buy |
View All
Nautilus Biotechnology Inc Stock (NAUT) Latest News
What the charts say about Nautilus Biotechnology Inc. todayQuarterly Trade Summary & Verified Entry Point Signals - Newser
Can momentum traders help lift Nautilus Biotechnology Inc.Insider Buying & Stock Portfolio Risk Control - Newser
Forecasting Nautilus Biotechnology Inc. price range with options dataJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - Newser
Nautilus Biotechnology Inc. stock prediction for this weekPortfolio Growth Summary & Real-Time Buy Signal Alerts - Newser
How to use a screener to detect Nautilus Biotechnology Inc. breakoutsInsider Selling & AI Powered Market Trend Analysis - Newser
How to read the order book for Nautilus Biotechnology Inc.Market Performance Recap & AI Driven Stock Price Forecasts - Newser
When is the best time to exit Nautilus Biotechnology Inc.Earnings Trend Report & Verified Short-Term Trading Plans - Newser
What machine learning models say about Nautilus Biotechnology Inc.2025 Buyback Activity & Weekly Return Optimization Alerts - Newser
Is it too late to sell Nautilus Biotechnology Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - Newser
What momentum shifts mean for Nautilus Biotechnology Inc.July 2025 Outlook & High Accuracy Trade Alerts - Newser
Nautilus Biotechnology Inc. stock volume spike explainedJuly 2025 Sentiment & Expert Verified Movement Alerts - Newser
Positive Signs As Multiple Insiders Buy Nautilus Biotechnology Stock - sg.finance.yahoo.com
Top chart patterns to watch in Nautilus Biotechnology Inc.Dividend Hike & AI Enhanced Trade Execution Alerts - Newser
Applying Wyckoff theory to Nautilus Biotechnology Inc. stock2025 Performance Recap & Technical Entry and Exit Alerts - Newser
Using flow based indicators on Nautilus Biotechnology Inc.Portfolio Return Report & Growth-Oriented Investment Plans - Newser
Sujal M. Patel Buys 83,500 Shares of Nautilus Biotechnology (NASDAQ:NAUT) Stock - MarketBeat
Insider Buying: Nautilus Biotechnology (NASDAQ:NAUT) CEO Acquires 116,500 Shares of Stock - MarketBeat
Combining machine learning predictions for Nautilus Biotechnology Inc.Portfolio Value Summary & High Conviction Investment Ideas - Newser
Trend analysis for Nautilus Biotechnology Inc. this weekEarnings Beat & Accurate Technical Buy Alerts - Newser
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Is Nautilus Biotechnology Inc. showing signs of accumulationWeekly Trade Review & Weekly Top Gainers Trade List - Newser
Intraday pattern recognizer results for Nautilus Biotechnology Inc.Portfolio Value Summary & Weekly Chart Analysis and Trade Guides - Newser
Is Nautilus Biotechnology Inc. a candidate for recovery playEarnings Trend Report & Weekly High Conviction Ideas - Newser
Is Nautilus Biotechnology Inc. stock risky to hold nowPortfolio Performance Summary & Community Consensus Trade Signals - beatles.ru
Nautilus Biotechnology, Inc. $NAUT Shares Sold by Bain Capital Life Sciences Investors LLC - MarketBeat
Nautilus Biotechnology Inc Stock (NAUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):